Lantheus Medical Imaging and GE Healthcare have signed a term sheet for the continued development of flurpiridaz F 18, an investigational positron emission tomography (PET) myocardial perfusion imaging (MPI) agent that may improve the diagnosis of coronary artery disease. {read more here}

A transportable brain-scanning helmet that could be used for rapid brain injury assessments of stroke victims and those felled on the sports pitch or battlefield is being tested by US scientists.

In September 2013, Medicare coverage for new oncologic PET radiopharmaceuticals underwent a quiet yet significant change. Up to this point, any new PET radiopharmaceuticals were required to go through a national coverage determination (NCD) for Medicare coverage. {read more here}